50881-0026 PEMAZYRE - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50881-0026

Brand Name:

PEMAZYRE

Generic Name:

Pemigatinib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: PEMIGATINIB

Strength: 4.5

Unit: mg/1

Packages:

Code: 50881-0026-01

Description: 14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01)

Effective Date: April 17, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FGFR1, FGFR2, FGFR3

Orphan Drug Designation:

Status:

In Use